Webinar: GM-CSF antibody for the treatment of cytokine storm in patients with severe COVID-19
In April, I-Mab, a clinical stage biopharmaceutical company committed [...]
In April, I-Mab, a clinical stage biopharmaceutical company committed [...]
The new reality of having to collaborate, share, and [...]